Semaglutide vs Tirzepatide — Which Weight Loss Injection Is Right for You in 2026
If you are researching semaglutide vs tirzepatide weight loss 2026 options, you are not alone. These two GLP-1 receptor agonist medications have become the most talked-about tools in medical weight management, and for good reason. Both can produce significant results — but they work differently, and the right choice depends on your biology, goals, and medical history. At TAP MedSpa in Mustang, Oklahoma, we help patients across the OKC metro understand their options and find the program that fits their life.
How Semaglutide Works
Semaglutide is a GLP-1 receptor agonist, originally developed to treat type 2 diabetes and later approved for chronic weight management under the brand names Ozempic and Wegovy. It works by mimicking a natural hormone that targets areas of the brain regulating appetite and food intake. When you take semaglutide, you feel fuller faster, experience fewer cravings, and your stomach empties more slowly. The result is a significant and sustained reduction in calorie intake without feeling deprived. In clinical trials, patients using semaglutide for weight loss lost an average of 15 percent of their body weight over 68 weeks.
How Tirzepatide Works
Tirzepatide is a dual agonist — it activates both GLP-1 and GIP receptors simultaneously. GIP, or glucose-dependent insulinotropic polypeptide, is a second gut hormone that enhances insulin response and plays a role in fat metabolism. By targeting both pathways, tirzepatide produces a more powerful combined effect on appetite suppression and metabolic function. In the SURMOUNT-1 clinical trial, patients on the highest dose of tirzepatide lost an average of 22.5 percent of their body weight — a result that exceeded anything previously seen in a weight loss medication trial.
Clinical Trial Results Comparison
Both medications have demonstrated remarkable results in large clinical trials, but tirzepatide shows a statistical advantage for total weight loss. Semaglutide produced an average of 15 percent body weight reduction in the STEP-1 trial, while tirzepatide reached up to 22.5 percent in the SURMOUNT-1 trial. However, clinical results are just one piece of the picture. Individual response to each medication varies significantly, and the best choice for you depends on factors beyond what a single number can tell. At TAP MedSpa, our weight loss consultations include a full health assessment to determine which medication aligns with your metabolic profile and health history.
Who Is a Better Candidate for Each?
Semaglutide is often a strong choice for patients who are new to GLP-1 therapy, those with cardiovascular risk who benefit from semaglutide’s well-established cardiac safety record, or patients who prefer a longer-studied medication. It is also sometimes better tolerated in terms of gastrointestinal side effects for certain individuals. Tirzepatide may be more appropriate for patients who have tried semaglutide without reaching their goals, those who have a higher body weight to lose, or individuals whose metabolic panel suggests significant insulin resistance. Tirzepatide’s dual mechanism also makes it a compelling option for patients with type 2 diabetes or prediabetes.
Cost Comparison
Cost is a real factor for many patients. Retail pricing for both medications without insurance can be significant. At TAP MedSpa, we offer compounded semaglutide and tirzepatide programs starting at competitive monthly rates, making medical weight loss more accessible to OKC metro patients. During your consultation, we will review current program pricing and help you understand the most cost-effective path to your goals. Explore our weight loss services page to learn more about what is included in each program.
Why Medical Supervision Matters
GLP-1 medications are highly effective, but they are not appropriate for everyone. Patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 should not use these medications. People with certain gastrointestinal conditions may need additional monitoring. This is why attempting to obtain these medications without medical guidance can be dangerous. At TAP MedSpa, all weight loss programs are supervised by Tanja Pittman DNP APRN CNP, who conducts thorough health screenings before starting any patient on a GLP-1 program. Medical supervision protects your safety and maximizes your results.
TAP MedSpa Weight Loss Program
TAP MedSpa is a clinical medical spa located in Mustang, Oklahoma, serving patients from across the OKC metro area including Yukon, Edmond, Moore, and beyond. Our weight loss program is built around personalized care. We start with a comprehensive consultation, review your health history, and design a program that fits your lifestyle and goals. Whether semaglutide or tirzepatide is the right fit for you, we will guide you every step of the way. Ready to get started? Visit our services page to learn about all we offer, or contact us to schedule your initial weight loss consultation today.
Which One Is Right for You? How TAP Decides
There is no universal winner between semaglutide and tirzepatide — the right choice depends on your health history, your weight loss goal, how your body responds, and your budget. At your consultation, Tanja Pittman, DNP, APRN, CNP, reviews your medications and labs, talks through side-effect tolerance, and recommends a starting point. Many Mustang and OKC-area patients begin with semaglutide for its lower monthly cost, then transition to tirzepatide if results plateau; others start on tirzepatide when there is more weight to lose. Either way, your dose is adjusted month by month based on real results — not a one-size-fits-all schedule. With programs starting as low as $200 per month and a free consultation that includes our $100-value Optic Elite Skin Analysis, call (405) 256-6060 or book online to find out which medication fits your goals — serving Mustang, Yukon, Edmond, and the OKC metro at 543 E State Hwy 152, Suite 101.